Bellerophon Therapeutics Inc (NASDAQ:BLPH)
| 6.80 Delayed Data As of Dec 03 |  +0.06 / +0.89%Today’s Change | 3.19 Today|||52-Week Range 26.00 | +29.63% Year-to-Date |
Latest BLPH News | Press Releases
No recent news for Bellerophon Therapeutics Inc.
Today’s Trading
| Previous close | 6.73 |
| Today’s open | 6.69 |
| Day’s range | 6.54 - 6.98 |
| Volume | 47,318 |
| Average volume (3 months) | 61,247 |
| Market cap | $64.7M |
Data as of 3:59pm ET, 12/03/2020
Growth & Valuation
| Earnings growth (last year) | -500.98% |
| Earnings growth (this year) | -14.83% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 8.64 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FBIOPFortress Biotech Inc | +0.06 | +0.31% |
| MGENmiRagen Therapeutics... | -0.06 | -0.36% |
| ---- | ||
| ---- |
Data as of 3:59pm ET, 12/03/2020
Financials
| Next reporting date | March 18, 2021 |
| EPS forecast (this quarter) | -$0.91 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$13.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Warren, New Jersey |
Forecasts
